Cardiac troponin I elevation and overall survival among cancer patients receiving investigational compounds during phase I trials

International Journal of Cardiology - Tập 214 - Trang 364-369 - 2016
Antoine Hollebecque1, Emilie Lanoy2, Frederic Troallen3, Laurie Soulat-Dufour4, Christophe Massard1, Rastislav Bahleda1, Andrea Varga1, Anas Gazzah1, Sophie Postel-Vinay1,5, Vincent Ribrag1, Eric Deutsch1,6, Eric Angevin1, Franck Boccara4, Ariel Cohen4, Jean-Charles Soria1,5, Stephane Ederhy4
1Drug Development Department (DITEP: Département d'Innovations Thérapeutiques et Essais Précoces), Gustave Roussy Cancer campus, 94805 Villejuif, France
2Service de biostatistique et épidémiologie, Gustave Roussy Cancer campus, 94805, Villejuif, France
3Département de biologie, Gustave Roussy Cancer campus, 94805 Villejuif, France
4Service de cardiologie, Hôpital Saint-Antoine, AP–HP, Université Pierre-et-Marie-Curie, Paris-Sorbonne, 75012 Paris, France
5INSERM Unit U981, Gustave Roussy Cancer Campus, 94805 Villejuif, France
6Département de radiothérapie, Gustave Roussy Cancer campus, 94805 Villejuif, France

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

International Journal of Cardiology

Tập 214

364-369

Thông tin tác giả